Phase III study of IV vinflunine in combination with methotrexate versus methotrexate alone in patients with recurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based chemotherapy (study L00070 IN 30
Phase III study of IV vinflunine in combination with methotrexate versus methotrexate alone in patients with recurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based chemotherapy (study L00070 IN 30
Phase III study of IV vinflunine in combination with methotrexate versus methotrexate alone in patients with recurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based chemotherapy (study L00070 IN 309 F0)
Statut
Status :
Terminé
Type d'étude
Phase III
Age Min.
18
Ans
Age Max.
80
Ans
Genre
Tous
Aire thérapeutique :
Oncologie
Maladie :
Carcinome épidermoïde
Traitement :
Vinflunine (Javlor®)
Phase :
Phase III
Date de début de l'étude :
02 Avril 2012
End date :
23 Novembre 2018
Identifiant de l'essai :
L00070 IN 309 F0
Identifiant EudraCT/CTIS :
2011-005081-38
Identifiant CT.gov :
NCT02347332
Envoyer par email